Prelude Therapeutics
PRLD
#8692
Rank
S$0.21 B
Marketcap
S$3.50
Share price
-6.21%
Change (1 day)
104.94%
Change (1 year)

Market capitalization of Prelude Therapeutics (PRLD)

Market cap: S$0.21 Billion

As of January 2026 Prelude Therapeutics has a market cap of S$0.21 Billion. This makes Prelude Therapeutics the world's 8692th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Prelude Therapeutics from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025S$0.19 B97.27%
2024S$0.10 B-67.58%
2023S$0.30 B-20.19%
2022S$0.38 B-51.64%
2021S$0.80 B-80.63%
2020S$4.13 B
2026S$0.21 B11.2%

End of Day market cap according to different sources

On Jan 1st, 2026 the market cap of Prelude Therapeutics was reported to be:

S$0.23 Billion
by Nasdaq info icon info icon
S$0.23 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
S$1.02 B 365.32%๐Ÿ‡บ๐Ÿ‡ธ USA